Value Educator Profile picture
Feb 1 • 14 tweets • 2 min read
#EaseMyTrip Q3 2022 Concall Highlights ✈🏨🛎

Like & retweet for better reach !

Financial Update.

1. Gross Booking Revenue (GBR) was Rs. 1,293 Crs up 44% QoQ basis and up 65% YoY.
2. Adjusted Revenue Rs. 152 Crs 147% YoY
3. Air Segment Booking 24.56 lacs 49% YoY.
4. Profit After Tax (PAT) Rs. 40 Crs 84% YoY
5. For 9M FY22 - Gross Booking Revenue (GBR) Rs. 2,544 Crs 108% YoY.
6. Adjusted Revenue Rs. 302 Crs 208% YoY.
7. Air Segment Booking 50.36 lacs 87% YoY.
8. Profit After Tax (PAT) Rs. 83 Crs 167%YoY.
9. 92.3% GMV comes from B2C business .
10. 88.8% transactions are done by B2C customers.
Business Update

1. Company’s employee expenses for Q3FY22 as a % of GBR stood at 0.5% compared to 0.6% for the same quarter last year. For 9MFY22 employee expenses as a % of GBR stood at 0.7% as compared to 1.2% for 9MFY21
2. With focused marketing & sales promotion expenses we have been able to increase our market share.
Marketing expenses stood at around 0.9% of GBR for 9MFY22 as compared to 0.8% of GBR in 9MFY21.
10. Other expenses as a % of GBR were consistent at 1.2% in 9MFY22 with 1.2% in 9MFY21.

11. Air Segments for the quarter were up by 49% and for 9MFY22 were up by 87%
12. Hotel nights booking in Q3FY22 & 9MFY22 were up by 144% & 357% respectively. We have achieved a new height in our hotel nights booking segment in 9MFY22 and are confident of future growth in this segment, with our competitive pricing & video offerings across hotels.
13. Recovery in travel & tourism sector has enabled high growth in bookings across segments.

14. The company acquired Spree Hospitality,a 1200 room-keys hospitality management company in order to expand presence in the hotel and holiday segment
Company paid 18.25Cr for this deal
15. Also Acquired Traviate which will add a new revenue stream and further strengthen the company’s offerings and portfolio in the B2B hotel and holiday space.
16. Traviate is India’s first B2B technology-driven travel marketplace that enables the travel ecosystem to connect and transact efficiently.
17. Company acquired Yolobus
By acquiring the brand name and technology of ‘Yolobus’, a premium intercity mobility platform, the company's plan is to grow presence in the non-air segment.
18. Company also decided First-ever brand ambassadors for the nationwide brand campaign, a 2 year contract.
Varun Sharma and Vijay Raaz were appointed as first-ever brand ambassadors as part of a nationwide brand initiative
19. Company declared total interim dividend payout of Rs. 32.59 Cr ; Announced one in May’21 (100%) and second in November (50%).
Future Outlook

1. Company also plans to acquire 2 more companies in coming quarters, with a vision of creating an ecosystem on the travel side and become a market leader in the coming 3-5 years.

2. Company expects its non-air revenue to double every year.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Value Educator

Value Educator Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ValueEducator

Feb 2
#HappiestMinds Q3 22 ConCall Highlights

Like & Retweet for better reach !

Numbers Update -

1. The revenue for Q3 stood at 284 cr up by 47.3% YoY and 7.3% QoQ

2. Total income for Q3 was 292 cr

3. EBITDA stood at 76 cr up by 27.8% YoY, PBT at 65 cr up by 22.8% YoY
4. EBITDA Margins were industry leading at 26.1%

5. DSO stood at 93 days

6. Attrition 21.1% TTM

Business Segments -

1. Product Engineering Services - The revenue from PES was 136.6 cr

2. Digital Business Services - The revenue from DBS stood at 85.11 cr
3. Infrastructure Management & Security Services - The revenue from IMSS stood at 63.22 cr

4. The revenue from automation was 27.1% of total revenue, reported separately because automation overlaps with all the business segments.
Read 9 tweets
Feb 2
Jubilant Ingrevia Q3 2022 Concall Highlights 🧪👨‍🔬

Like & Retweet for better reach !

Operational Highlights

1. Revenue grew by 44% on YoY basis, driven by growth across product segments to ₹1,286 cr in Q3FY22 from ₹893 cr in Q3FY21
2. Revenue from Pharma, Nutrition and Agro end use increased significantly.

3. Most of the input cost is passed on resulting in better realisations

4. Acetic acid prices were high due to china and supply constraints
The change in duty for acetic anhydride and methanol will benefit more to consumers than the manufacturers
Read 17 tweets
Feb 2
#NeulandLabs Q3 FY22 concall highlights 💊💊

Like & retweet for better reach !

1. Revenue for the quarter is ₹238.4 Cr (2.9% decline YoY). EBITDA for the quarter was ₹34.2 Cr (26.8% decline YoY) with an EBITDA margin of 14.3%.
2. They are facing supply chain issues due to raw material volatility and high logistics cost. They also benefited in the last few quarters due to raw material hedging for key ingredients, but those contracts expired in Q2 which caused a decline in margins.
They are holding higher inventory in case of possible future disruptions.
3. Currently profitability is low due to costs associated with commercialization on Unit 3. They expect more volumes from Unit 3 in the coming quarters.
Read 22 tweets
Feb 1
#AjantaPharma Q3 FY22 concall highlights 💊🧪

Like and retweet for better reach !

1. The company has announced a buyback of ₹352 Cr including taxes. Including dividend, total payout to the shareholder for the financial year is at ₹434 Cr
2. Emerging Markets business (Branded Generics) - Spread across Asia and Africa and contributes 41% of revenues. Exports to these markets were ₹361 Cr (26% growth YoY).
Sales to Asia were ₹194 Cr (1% decline YoY). Sales to Africa were ₹167 Cr (87% growth YoY) however growth looks higher due to low base effect.

3. US Generic Business - Contributed 22% of revenues. Sales were ₹166 Cr(3% growth YoY).
Read 16 tweets
Feb 1
#Punjabchemicals Q3 2022 Concall Highlights
🧪👨‍🔬

Like & retweet for better reach !

Operations Highlights

1. The revenue for Q3FY22 grew by 22% QoQ to ₹255 Cr from ₹208.8 Cr in the previous quarter.
2. Gross margins stood at 37% in Q3FY22 compared to 40.6% in previous quarter, degrowth of (-362 bp)

3. 53.05% contribution of revenue from exports and 46.9% from domestic markets

4. Top 10 products contributed 65%+ revenues in 9MFY22
5. The contracts with Nippon Kayaku and a japanese company are performing well, the clients are satisfied with the product quality and high demand for molecules is anticipated
Read 10 tweets
Feb 1
#InfoEdge Q3 22 Concall Highlights 💻🍔

Like & Retweet fir better reach !

Consolidated Financials

1. Record Q3 Billing at ₹468.1 crore, up ~58% YoY. Billing including acquired operating businesses
(IIMjobs, Zwayam and DoSelect) at ₹486.4 crore, up ~60% YoY

2. YTD Billing ₹1184.6Cr a YoY growth of 61%.

3. Q3 Revenue at ₹403.3 crore, up ~48% YoY.

4. Adjusted PBT for Q3 stood at ₹2621.1Cr.

5. YTD Revenue at ₹1074.7 crore, up ~33% YoY.
6. Operating EBITDA stood at ₹212.1 Cr vs ₹68.2 Cr last year growth of 64.4% from Q3 2021 and 6% Q3 2020.

7. Operating expense excluding depreciation and amortization was ₹291.2 Cr up 42.7% YoY, primarily driven by advertising and promotion spends.
Read 22 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

:(